We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Injectable Gel Repairs Torn Cartilage

By HospiMedica staff writers
Posted on 21 Dec 2004
An injectable gel is being developed that could speed the repair of torn cartilage and help injured athletes return to competition sooner, according to researchers at the Massachusetts Institute of Technology (MIT) and Harvard Medical School (both in Boston, MA, USA).

The new technique uses the patient's own cartilage-producing cells and is less invasive than conventional cartilage repair techniques, which may include surgery and a slow, painful recovery. More...
When the liquid mixture is injected into areas where cartilage is torn, such as a knee joint, the material hardens into a gel upon exposure to ultraviolet light, leaving the transplanted cells in place so they can grow new cartilage where it is needed. The gel material is composed of a natural polysaccharide called hyaluronic acid, which is modified with photoreactive groups (methacrylates) and a photosensitive molecule.

In a proof-of-concept experiment, the researchers implanted cartilage-producing cells obtained from the ears of pigs under the skin of a small group of mice. The material produced progressively higher amounts of healthy new cartilage over the three-month study period. Although ultraviolet light is used in the current gelling process, the scientists say the process can eventually be performed using visible light.

"The gel itself won't initially replace damaged cartilage, but will provide an optimum growth environment for implanted cartilage-producing cells so that new cartilage can be formed and help restore function,” explained lead author Jason A. Burdick, Ph.D., a postdoctoral fellow at the department of chemical engineering at MIT (www.mit.edu). The new technique is described in the January 10, 2005, issue of Biomacromolecules.

Dr. Burdick predicts that one day it may be possible to use the technique to repair worn cartilage covering large surface areas, such as arthritic joints, or used to "clay” custom-mold new cartilages outside the body for eventual use in plastic surgery reconstruction, such as building new ears and noses.




Related Links:
MIT

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Bipolar Coagulation Generator
Aesculap
Ureteral Dilatation Balloon
Dornier Equinox
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.